Abstract
BackgroundRanibizumab is the elected treatment in retinal pathologies, that produces a negative impact on patients’ vision-related quality of life (vrQoL).PurposeTo evaluate the effect of ranibizumab in vrQoL in patients with...
Accepted Version
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have